Moderna shares double after experimental mRNA cancer treatment passes key test
Aug 20, 2026
Washington [US], August 20: Moderna shares more than doubled Wednesday after it announced initial results from a study of an experimental cancer treatment that would be the first of its kind if approved by regulators.
Read More ..